XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
EXAGEN INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$7.43−0.29 (-3.76%)
Close on Oct 19, 2026
- Market cap
- $179.54M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$66.58MFY2025, +10.8% a year since FY2018